2023-507060-39-00招募中1 期
A phase 1 study of GSK2857916 + Standard of Care (SOC) in first line multiple myeloma patients (DREAMM-9)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 67
- 试验地点
- 13
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
EU GSK Clinical Trials Call Center
Scientific
Glaxosmithkline Research & Development Limited
研究点 (13)
Loading locations...
相似试验
招募中
1 期
A study for GSK3862995B in healthy participants and participants with Chronic Obstructive Pulmonary Disease2023-506880-32-01Glaxosmithkline Research & Development Limited55
招募中
1 期
A Phase 1 study of GSK5764227 in participants with advanced solid tumors2024-513663-10-01Glaxosmithkline Research & Development Limited, Glaxosmithkline Research & Development Limited112
已完成
1 期
MK-1403 Single Dose Formulation PK StudyAtherosclerosis2023-507984-20-00Merck Sharp & Dohme LLC16
招募中
3 期
MK-2870 in Post Platinum and Post Immunotherapy Endometrial Cancer2023-504816-14-00Merck Sharp & Dohme LLC267
已完成
1 期
A clinical study of MK-2828 in healthy people (MK-2828-001)Atherosclerosis2024-513377-51-00Merck Sharp & Dohme LLC16